A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study

@article{Salvatore2014A1T,
  title={A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study},
  author={Stefano Salvatore and Rossella Elena Nappi and Nicola Zerbinati and A L Calligaro and Simone Ferrero and Massimo Origoni and Massimo Candiani and Umberto Leone Roberti Maggiore},
  journal={Climacteric},
  year={2014},
  volume={17},
  pages={363 - 369}
}
Abstract Objective This pilot study aimed to assess the efficacy and feasibility of fractional CO2 laser in the treatment of vulvovaginal atrophy (VVA) in postmenopausal women. Methods VVA symptoms were assessed before and after three applications of laser over 12 weeks in 50 women (age 59.6 ± 5.8 years) dissatisfied with previous local estrogen therapies. Subjective (visual analog scale) and objective (Vaginal Health Index Score, VHIS) measures were used during the study period to assess VVA… Expand

Paper Mentions

Interventional Clinical Trial
To assess the long-term histological and clinical efficacy of MonaLisa Touch procedure for the management of the Genitourinary Syndrome of Menopause (GSM) in postmenopausal female… Expand
ConditionsBreast Cancer Female, Dyspareunia, Vaginal Atrophy
InterventionDevice
Interventional Clinical Trial
This study is being done to compare the effects, good and bad, of fractionated CO2 laser treatment and clobetasol proprionate .05% ointment on vulvar lichen sclerosus.  
ConditionsVulvar Lichen Sclerosus
InterventionDevice, Drug
Interventional Clinical Trial
This trial seeks to determine if therapy with a CO2 laser to the vagina is more effective than lidocaine to the opening of the vagina before intercourse to reduce painful intercourse… Expand
ConditionsDyspareunia
InterventionDevice, Drug
Interventional Clinical Trial
Forty-five women will be included in a double-blind randomized trial in order to compare fractional CO2 laser treatment, local estrogen therapy and the combination of both treatments… Expand
ConditionsVulvovaginal Atrophy
InterventionDevice, Drug
Fractional CO2 Laser for Treatment of Vulvovaginal Atrophy: A Short Time Follow-up
TLDR
It seems vaginal fractional CO2 laser can be applied as an effective and safe treatment method in genitourinary syndrome of menopause (GSM), it is necessary to conduct studies with long-term follow-up. Expand
ulvo-vaginal atrophy : A new treatment modality using hermo-ablative fractional CO 2 laser
Objective: To evaluate the efficacy and feasibility of thermo-ablative fractional CO2 laser for the treatment of symptoms related to vulvo-vaginal atrophy (VVA) in post-menopausal women. Methods:Expand
Fractional CO2 laser therapy: a new challenge for vulvovaginal atrophy in postmenopausal women
TLDR
This study shows that CO2 laser treatment induces a significant and long-lasting improvement of symptoms and this improvement was long lasting. Expand
Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser.
TLDR
Thermo-ablative fractional CO2 laser could be a safe, effective and feasible option for the treatment of VVA symptoms in post-menopausal women. Expand
An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy
TLDR
The data suggest that the fractional CO2 laser is effective and safe for treatment of the symptoms associated with GSM. Expand
Safety evaluation of fractional CO2 laser treatment in post-menopausal women with vaginal atrophy: A prospective observational study.
TLDR
Fractional CO2 laser for treatment of VVA seems a safe therapeutic option, and patients were highly satisfied, and they would repeat laser treatment. Expand
Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy
TLDR
Fractional microablative CO2 laser treatment is associated with a significant improvement of sexual function and satisfaction with sexual life in postmenopausal women with VVA symptoms. Expand
Microablative Fractional CO2 Laser Improves Dyspareunia Related to Vulvovaginal Atrophy: A Pilot Study
TLDR
Treatment with the microablative fractional CO2 laser of patients with dyspareunia related to VVA was efficacious at 12-week follow-up and a significant improvement in quality of life (QoL) and sexual function were shown. Expand
Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy
TLDR
Fractional microablative CO 2 laser treatment is associated with a signifi cant improvement of sexual function and satisfaction with sexual life in postmenopausal women with VVA symptoms. Expand
Early effect of fractional CO2 laser treatment in Post-menopausal women with vaginal atrophy.
TLDR
CO2 laser therapy for post-menopausal women can be considered an effective therapeutic option providing relief of symptoms already noted after one laser treatment, and almost all VVA symptoms were significantly improved at one month following the first treatment. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 63 REFERENCES
Ablative fractionated CO2, laser resurfacing for the neck: prospective study and review of the literature.
TLDR
AFP was both safe and effective for the treatment of neck laxity, rhytids and skin texture and the degree of improvement observed in wrinkling, texture and laxity after AFP coupled with the benign side effect profile has not been reported with previous trials of ablative laser resurfacing of the neck. Expand
Fractional laser resurfacing for acne scars: a review
TLDR
This review investigates the effectiveness of ablative and nonablative fractional photothermolysis (FP) lasers for treating facial acne scars and finds that a higher proportion of patients who underwent ablative FP experienced postinflammatory hyperpigmentation (PIH) than those who hadNonablative FP. Expand
Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview
  • A. Sinha, A. Ewies
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2013
TLDR
Vaginal moisturizers may have an equivalent efficacy to topical vaginal estrogen and should be offered to women wishing to avoid the use of hormonal therapy, and lubricants are usually used during sexual intercourse to provide temporary relief from vaginal dryness and dyspareunia. Expand
Fractionated Carbon Dioxide Laser Treatment of Photoaging: Prospective Study in 45 Patients and Review of the Literature
TLDR
Significant improvement in photoaging of the face can be achieved using an AFP device with skin types I to III after a series of two to three treatments. Expand
Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy
TLDR
The findings of this 52-week study confirm the tolerance and efficacy of oral ospemifene previously reported in short- and long-term studies. Expand
Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey.
TLDR
Significant barriers to treatment include lack of knowledge about VVA, reluctance to discuss symptoms with HCPs, safety concerns, inconvenience, and inadequate symptom relief from available treatments. Expand
Efficacy and tolerability of local estrogen therapy for urogenital atrophy
TLDR
Urogenital atrophy should not be considered an inevitable consequence of menopause because various hormonal and nonhormonal products are available to relieve symptoms, and postmenopausal estrogen therapy is the most logical choice for treatment. Expand
Rejuvenation of the Aging Chest: A Review and Our Experience
  • J. Peterson, M. Goldman
  • Medicine
  • Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • 2011
TLDR
Review of the literature revealed that options for minimally invasive treatment options for rejuvenation of the skin of the chest include injectable PLLA, botulinum toxin, sclerotherapy, and chemical peels, along with lasers and light therapies such as IPL, PDT, and nonablative fractionated lasers. Expand
Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach
TLDR
The most bothersome symptom approach represents a meaningful new standard for measurement of self-assessed vulvovaginal atrophy symptom change, but evaluation of change in individual symptoms remains an important, unbiased primary analysis of efficacy in vulvous atrophy studies. Expand
...
1
2
3
4
5
...